Article
Novel application of luciferase assay for the in vitro functional assessment of KAL1 variants in three females with septo-optic dysplasia (SOD).
Molecular and cellular endocrinology - 5 Dec 2015
McCabe Mark J, Hu Youli, Gregory Louise C, Gaston-Massuet Carles, Alatzoglou Kyriaki S, Saldanha José W, Gualtieri Angelica, Thankamony Ajay, Hughes Ieuan, Townshend Sharron, Martinez-Barbera Juan-Pedro, Bouloux Pierre-Marc, Dattani Mehul T
Abstract excerpt
KAL1 is implicated in 5% of Kallmann syndrome cases, a disorder which genotypically overlaps with septo-optic dysplasia (SOD). To date, a reporter-based assay to assess the functional consequences of KAL1 mutations is lacking. We aimed to develop a luciferase assay for novel application to functional assessment of rare KAL1 mutations detected in a screen of 422 patients with SOD. Quantitative analysis was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
